Amyloidopathy

However, it has been suggested that J20 transgenic model has its limitations in representing the full aspects of amyloidopathy in AD cases [16 ]; and it would be desirable to examine synaptosomal mitochondrial dysfunction in different animal models with a better representation of amyloidopathy in AD brains.